Bauer Eugene bought EVMN
November 7, 2025 · Form 4 insider transaction
Bauer Eugene bought 25,812 shares of Evommune, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,812
Price
N/A
Total value
N/A
InsiderBauer Eugene
RoleOfficer, Director
CompanyEvommune, Inc. (EVMN)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after272,296
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date.; Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date.